From: Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trial
Placebo survival rate
Adrenaline survival rate
30-day survival rate 6%
6%
7%
8%
30-day survival rate 3%
3%
4%
5%
30-day survival rate 2%
2%